MS Speaks
Here for 17 years--for people with an interest in multiple sclerosis
Welcome,
Guest
. Please
login
or
register
.
1 Hour
1 Day
1 Week
1 Month
Forever
Login with username, password and session length
This topic
This board
Entire forum
Home
Search
Today's Posts
Contact
Login
Register
MS Speaks 5/06 to 11/13
MS Speaks
»
Forum
»
Multiple Sclerosis
»
TREATMENTS
»
LEMTRADA (Campath, alemtuzumab)
»
Drug company merger affects Lemtrada
« previous
next »
Print
Pages: [
1
]
Author
Topic: Drug company merger affects Lemtrada (Read 113 times)
0 Members and 2 Guests are viewing this topic.
agate
Administrator
Posts: 9822
MS diagnosed 1980
Location: Pacific Northwest
Drug company merger affects Lemtrada
«
on:
November 13, 2015, 08:32:09 am »
Calling attention to this thread in the Research/Discussion section:
http://msspeaks.createaforum.com/general-discussion/drug-company-merger-may-be-bad-news-for-ms-drug-lemtrada/
Report to moderator
Logged
MS Speaks--online for 17 years
SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Print
Pages: [
1
]
« previous
next »
MS Speaks
»
Forum
»
Multiple Sclerosis
»
TREATMENTS
»
LEMTRADA (Campath, alemtuzumab)
»
Drug company merger affects Lemtrada